The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
16 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,254,024 in first-year total cost, median $533,017.
Most frequent study sections
- Drug Discovery for the Nervous System Study Section[DDNS]14
- Special Emphasis Panel[ZRG1 MDCN-B (05)]2
Most frequent institutions
- UNIVERSITY OF CALIFORNIA LOS ANGELES3
- UNIVERSITY OF TEXAS MED BR GALVESTON2
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- LIEBER INSTITUTE, INC.1
- NORTH DAKOTA STATE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Novel Drug Discovery for AD Targeting Ryanodine Calcium Channels1RF1AG047237-01A1 | BUOLAMWINI, JOHN KSTUTZMANN, GRACE E. | ROSALIND FRANKLIN UNIV OF MEDICINE & SCI, IL | $1,950,000 | DDNS |
| 2016 | Lead optimization of Novel mGlu2 Negative Allosteric Modulators1R01MH106865-01A1 | COSFORD, NICHOLAS DAVIDDER-AVAKIAN, ANDRE | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $896,201 | DDNS |
| 2016 | Development of Nociceptin Receptor Agonists for Post-Traumatic Stress Disorder1R01MH110441-01 | BROTHERS, SHAUN P | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $844,016 | DDNS |
| 2016 | Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders2R01MH092769-06A1 | BURRIS, THOMAS PWALKER, JOHN K. | SAINT LOUIS UNIVERSITY, MO | $662,214 | DDNS |
| 2016 | Small molecule modulators of ΔFosB function1R01DA040621-01A1 | NESTLER, ERIC J.RUDENKO, GABRIELLEZHOU, JIA | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $635,178 | ZRG1 |
| 2016 | Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimer’s Disease1R01AG051574-01A1 | KANEKIYO, TAKAHISASINGH, JAGDISH | NORTH DAKOTA STATE UNIVERSITY, ND | $388,125 | DDNS |
| 2015 | Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia1R01MH107126-01 | BARROW, JAMES | LIEBER INSTITUTE, INC., MD | $915,650 | DDNS |
| 2015 | Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain1R01DA038635-01A1 | ANANTHAN, SUBRAMANIAM | SOUTHERN RESEARCH INSTITUTE, AL | $912,586 | DDNS |
| 2015 | Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease1R01AG047858-01A1 | WITT, KEN A | SOUTHERN ILLINOIS UNIV AT EDWARDSVILLE, IL | $553,610 | DDNS |
| 2015 | ApoE4-targeted therapeutics that normalize SirT11R01AG051386-01 | JOHN, VARGHESE | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $512,424 | DDNS |
| 2015 | 5‐HT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER1R01DA038446-01A1 | CUNNINGHAM, KATHRYN A.ZHOU, JIA | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $436,045 | ZRG1 |
| 2015 | Non-peptide Mu Opioid Receptor Selective Antagonists2R01DA024022-06A1 | ZHANG, YAN | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $381,250 | DDNS |
| 2015 | Misfolded protein clearance enhancers for Alzheimers therapy1R01AG050721-01 | BITAN, GAL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $284,130 | DDNS |
| 2014 | GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction1R01DA037270-01 | ABOU-GHARBIA, MAGIDROTHSTEIN, JEFFREY D | TEMPLE UNIV OF THE COMMONWEALTH, PA | $504,440 | DDNS |
| 2014 | Drug Discovery against the Early, Secreted and Toxic Tau in Alzheimer's Disease1R01AG046319-01A1 | LU, KUN PING | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $356,700 | DDNS |
| 2014 | Stimulating oligodendrocyte progenitor cell differentiation and remyelination1R01NS081141-01A1 | TIWARI-WOODRUFF, SEEMA K | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $21,455 | DDNS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.